Download presentation
Presentation is loading. Please wait.
Published byKatherine Walters Modified over 6 years ago
1
Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis Paloma López-Beret, MD, Antonio Orgaz, MD, Juan Fontcuberta, MD, Manuel Doblas, MD, Adela Martinez, RVT, Gloria Lozano, RVT, Arturo Romero, MD Journal of Vascular Surgery Volume 33, Issue 1, Pages (January 2001) DOI: /mva Copyright © 2001 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions
2
Fig. 1 Complications after long-term treatment of DVT. LMWH, Low molecular weight heparin; NS, not statistically significant; OA, oral anticoagulant. Journal of Vascular Surgery , 77-90DOI: ( /mva ) Copyright © 2001 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions
3
Fig. 2 Effect of both treatments on the evaluation of thrombosis expressed by quantitative duplex scan score according to DVT level. DVT, Deep venous thrombosis; LMWH, low molecular weight heparin; NS, not significant; OA, oral anticoagulant; *statistically significant. Journal of Vascular Surgery , 77-90DOI: ( /mva ) Copyright © 2001 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions
4
Fig. 3 Regression of thrombus size according to duplex scan examination in proximal venous segments. LMWH, Low molecular weight heparin; NS, Not significant; OA, oral anticoagulant; *statistically significant. Journal of Vascular Surgery , 77-90DOI: ( /mva ) Copyright © 2001 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.